Evidence map›Paper›PMID 25054560›Full record

ArticlePloS one2014

PGE₂ promotes apoptosis induced by cytokine deprivation through EP3 receptor and induces Bim in mouse mast cells.

Martina Kovarova, Beverly H Koller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Apoptosis and eryptosis: similarities and differences.Apoptosis : an international journal on programmed cell death · 2024
    Review
  2. Development of pharmacotherapies for abdominal aortic aneurysms.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  3. Article
  4. Article
  5. [Association between BIM gene and glucocorticoid resistance in children with acute lymphoblastic leukemia].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2017
    Review
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Martina KovarovaDepartment of Medicine, Pulmonary Division, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
Beverly H KollerDepartment of Medicine, Pulmonary Division, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America; Department of Genetics, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States of America.
University of North Carolina at Chapel Hill · US

Funding

PGE2 in the Pathogenesis of Allergic Airways DiseaseR01HL068141 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KOLLER, BEVERLY H · 2001 to 2009
$3.2M
Prostaglandin E2 and Regulation of Kidney FunctionR01DK069896 · NIDDK · DUKE UNIVERSITY · PI COFFMAN, THOMAS M · 2005 to 2013
$2.6M
NHLBI NIH HHS HL068141NHLBI NIH HHS R01 HL068141NIDDK NIH HHS DK069896NIDDK NIH HHS R01 DK069896
6 · The paper itself

Abstract

Increased mast cell numbers are observed at sites of allergic inflammation and restoration of normal mast cell numbers is critical to the resolution of these responses. Early studies showed that cytokines protect mast cells from apoptosis, suggesting a simple model in which diminished cytokine levels during resolution leads to cell death. The report that prostaglandins can contribute both to recruitment and to the resolution of inflammation together with the demonstration that mast cells express all four PGE2 receptors raises the question of whether a single PGE2 receptor mediates the ability of PGE2 to regulate mast cell survival and apoptosis. We report here that PGE2 through the EP3 receptor promotes cell death of mast cells initiated by cytokine withdrawal. Furthermore, the ability of PGE2 to limit reconstitution of tissues with cultured mast cells is lost in cell lacking the EP3 receptor. Apoptosis is accompanied by higher dissipation of mitochondrial potential (ΔΨm), increased caspase-3 activation, chromatin condensation, and low molecular weight DNA cleavage. PGE2 augmented cell death is dependent on an increase in intracellular calcium release, calmodulin dependent kinase II and MAPK activation. Synergy between the EP3 pathway and the intrinsic mitochondrial apoptotic pathway results in increased Bim expression and higher sensitivity of mast cells to cytokine deprivation. This supports a model in which PGE2 can contribute to the resolution of inflammation in part by augmenting the removal of inflammatory cells in this case, mast cells.

Indexed as

AnimalsApoptosisApoptosis Regulatory ProteinsBcl-2-Like Protein 11CalciumCytokinesDinoprostoneMast CellsMembrane ProteinsMiceMice, KnockoutProto-Oncogene ProteinsReceptors, Prostaglandin E, EP3 SubtypeSignal TransductionApoptosis Regulatory ProteinsBcl2l11 protein, mouseBcl-2-Like Protein 11CalciumCytokinesDinoprostoneMembrane ProteinsProto-Oncogene ProteinsReceptors, Prostaglandin E, EP3 Subtype

Identifiers

PMID25054560
PMCPMC4108439
OpenAlexW1965267304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.